12

News

Iconovo initiates structured sales process for ICOpre

Read more

Study start for Monash University with inhaled oxytocin in ICOone

Read more

Årsredovisning för 2022 publicerad

Read more

PRODUCTS

Four differentiated technical platforms, available for customization

Iconovo offers the development of inhalation products — inhaler devices and dry powder formulation — and assists in clinical trials and registration. We also offer proprietary generic drugs. The inhalation platforms are primarily intended for asthma and chronic obstructive pulmonary disease (COPD) treatment.

Learn more…

SERVICES

Seeking a fast and safe way to reach the market?

We work with international generic drug companies and pharmaceutical companies that lack the expertise, resources and/or time to develop the product themselves. Our development time is shorter and consequently more cost-effective since we have ready-to-use platforms with inhalation products that can be modified for a specific drug.

Learn more…

CAPABILITIES

A unique combination of engineering and pharmaceutical expertise

Iconovos highly skilled employees offers a comprehensive service package including device design, formulation development, analytical testing and documentation. Iconovo has build its own state-of-the-art laboratories for analysis, development and characterization of powder formulations.
Learn more…

Read more about our customer collaborations

Want to know when we got news on our platforms? Sign up for our press releases now!